|1|Targeted androgen pathway suppression in localized prostate cancer: a pilot study. (24323034)
Mostaghel E.A.... Montgomery B.
|2|FROGG high-risk prostate cancer workshop: Patterns of practice and literature review. Part II post-radical prostatectomy. (24345209)
Lehman M.... Tai K.H.
|3|IgG4-Related Autoimmune Prostatitis: Is It an Unusual or Underdiagnosed Manifestation of IgG4-Related Disease? (24349818)
Bourlon M.T.... Arceo-Olaiz R.
|4|Transabdominal ultrasound measurement of pelvic floor muscle mobility in men with and without chronic prostatitis/chronic pelvic pain syndrome. (22925244)
Khorasani B.... Assadi H.
|5|Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome. (23017785)
Qi X.... Zhou X.
|6|The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells. (22179513)
Zhang P.J.... Jiang A.L.
|7|Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. (20952019)
Magri V.... Weidner W.
|8|Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis. (18639473)
de SA! V.K.... Leite K.R.
|9|Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity. (19706801)
Christensen E.... Bristow R.G.
|10|Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor. (19883429)
Tang M.... Shirai T.
|11|Growth inhibitory effect of KrA1ppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines. (18719336)
Cheng X.F.... Hattori T.
|12|Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress. (18663430)
Hsiao C.J.... Guh J.H.
|13|Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia. (18386288)
Wang W.... Takayama T.K.
|14|Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities. (17462482)
Forrest J.B.... Moldwin R.M.
|15|Neuroendocrine differentiation in prostate adenocarcinoma. (17985422)
|16|Increased levels of IgG antibodies against peptides of the prostate stem cell antigen in the plasma of pancreatic cancer patients. (17549363)
Tanaka M.... Itoh K.
|17|Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate:a potential pitfall. (17660340)
Lim T.K.... Tan P.H.
|18|Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer. (17096324)
Johansson M.... Kaaks R.
|19|Synergistic effects of radiation and beta-lapachone in DU-145 human prostate cancer cells in vitro. (16669706)
Suzuki M.... Song C.W.
|20|Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level. (16943536)
D'Amico A.V.... Chen M.H.
|21|A role for the WWOX gene in prostate cancer. (16818616)
Qin H.R.... Huebner K.
|22|Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and Rho kinase-1. (16407310)
Zihni C.... Morris J.D.
|23|Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. (16401639)
Li Z.... Efstratiadis A.
|24|Prostate-specific membrane antigen expression predicts prostate cancer recurrence. (16841802) |2006|
|25|The chromogranin-A (CgA) in prostate cancer. (16280180)
Ranno S.... Malaguarnera M.
|26|Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. (16880611)
Chang H.K.... Kim C.J.
|27|Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. (15681524)
Lawton C.A.... Pilepich M.V.
|28|A role for surfactant protein D in innate immunity of the human prostate. (15948134)
Oberley R.E.... Snyder J.M.
|29|Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines. (15389789)
Mimeault M.... HAcnichart J.P.
|30|Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens. (16139948)
Rubio J.... Llombart-Bosch A.
|31|Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues]. (15191726)
Wang F.L.... Li K.N.
|32|p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. (15263792)
Wu H.C.... Chen W.C.
|33|PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer. (15264248)
Buchanan G.... Tilley W.D.
|34|FGF8 isoform b expression in human prostate cancer. (12778074)
Gnanapragasam V.J.... Leung H.Y.
|35|Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. (12883385)
Kidd L.C.... Tangrea J.A.
|36|Radiosensitivity with Par-4 expression in prostate cancer. (12212614)
|37|Molecular markers in prostate cancer: the role in preoperative staging. (15046712)
Moul J.W.... Srivastava S.
|38|A novel anti-proliferative property of clusterin in prostate cancer cells. (12409141)
Zhou W.... Lee C.
|39|Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma. (11596021)
DiPaola R.S.... Todd M.B.
|40|Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. (11506501)
Lang S.H.... Maitland N.J.
|41|Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma. (10840458)
Kibel A.S.... Isaacs W.B.
|42|Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma. (10338074)
Konishi N.... Hirao Y.
|43|Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer. (10373563)
Abreu-Martin M.T.... Sawyers C.L.
|44|Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy. (9495713)
D'Amico A.V.... Tempany C.M.
|45|Importance of vitamin D in prostatic carcinoma]. (8998822)
Wilczek H.... VachalovskA1 .
|46|Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. (7639332)
Humphrey P.A.... Day M.L.
|47|Detection of prostate-specific antigen immunoreactivity in breast tumors. (7532468)
Diamandis E.P.... Sutherland D.J.
|48|Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. (7987830)
Zenklusen J.C.... Conti C.J.
|49|Utilization of bone scans in conjunction with prostate-specific antigen levels in the surveillance for recurrence of adenocarcinoma after radical prostatectomy. (1715394)
Terris M.K.... Stamey T.A.
|50|Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. (2351105)
Grima J.... Cheng C.Y.